SKI Market

A+| A| A-|

Indian Indices

Sensex

76,200.68 -893.39
( -1.16%)

Global Indices

Nasdaq

51,704.04 -29.67
(-0.06%)

Dow Jones

7,389.07 -104.72
(-1.40%)

Hang Seng

70,132.76 -2,221.20
(-3.07%)

Nikkei 225

10,454.55 16.70
(0.16%)

Forex

USD-INR

94.32 -0.07
(-0.07%)

EUR-INR

108.15 -0.25
(-0.23%)

GBP-INR

124.70 -0.38
(-0.31%)

JPY-INR

0.58 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

38.01

939.36

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.06

Back

Board of Remus Pharmaceuticals recommends final dividend

May 21,2026

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

76,200.68 -893.39 ( -1.16%)

51,704.04 -29.67 (-0.06%)

7,389.07 -104.72 (-1.40%)

70,132.76 -2,221.20 (-3.07%)

10,454.55 16.70 (0.16%)

94.32 -0.07 (-0.07%)

108.15 -0.25 (-0.23%)

124.70 -0.38 (-0.31%)

0.58 0.00 (-0.32%)